Metabolic and structural effects of phosphatidylcholine and deoxycholate injections on subcutaneous fat: A randomized, controlled trial

Aesthetic Surgery Journal

Volumn 33, Issue 3, 2013, Pages 400-408

  Reeds, Dominic N ^a   Mohammed, B Selma ^c   Klein, Samuel ^a   Boswell, Craig Brian ^b   Young, V Leroy ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Private Practice   (United States)

^c NONE

Author keywords

body contouring; fat ablation; injection lipolysis; Lipodissolve

Indexed keywords

ADIPONECTIN; ALPHA INTEGRIN; C REACTIVE PROTEIN; CASPASE 8; CD36 ANTIGEN; COLLAGEN TYPE 4; DEOXYCHOLIC ACID; FATTY ACID SYNTHASE; GLUCOSE; GLUCOSE REGULATED PROTEIN 78; HORMONE SENSITIVE LIPASE; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLCHOLINE; TRIACYLGLYCEROL LIPASE; VASCULOTROPIN;

ABDOMINAL FAT ASPIRATION BIOPSY; ABDOMINAL SUBCUTANEOUS FAT; ADIPOCYTE; ADIPOSE TISSUE; ADULT; APPLICATION SITE PAIN; ARTICLE; BODY COMPOSITION; BODY MASS; BURNING SENSATION; CELL FUNCTION; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; EDEMA; ERYTHEMA; FEMALE; FLUSHING; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERPIGMENTATION; INJECTION SITE CONTUSION; LIPID ANALYSIS; LIPOSUCTION; MACROPHAGE; METABOLISM; NAUSEA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKINFOLD THICKNESS;

ABSORPTIOMETRY, PHOTON; ADIPOCYTES; ADIPOSITY; ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BIOPSY; BLOOD GLUCOSE; COSMETIC TECHNIQUES; DEOXYCHOLIC ACID; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; INJECTIONS, SUBCUTANEOUS; LIPIDS; LIPOLYSIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MISSOURI; NECROSIS; PATIENT SATISFACTION; PHOSPHATIDYLCHOLINES; SUBCUTANEOUS FAT, ABDOMINAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 84875554095     PISSN: 1090820X     EISSN: 1527330X     Source Type: Journal    
DOI: 10.1177/1090820X13478630     Document Type: Article

References (30)

1. American Society for Aesthetic Plastic Surgery. 2011Cosmetic Surgery National Data Bank Statistics. http://www.surgery.org/media/statistics.
2. Duncan DI, Palmer M. Fat reduction using phosphatidylcholine/sodium deoxycholate injections: standard of practice. Aesthetic Plast Surg. 2008 ; 32 (6). 858-872
3. Matarasso A, Pfeifer TM. Mesotherapy and injection lipolysis. Clin Plast Surg. 2009 ; 36 (2). 181-192
4. Rotunda AM, Kolodney MS. Mesotherapy and phosphatidylcholine injections: historical clarification and review. Dermatol Surg. 2006 ; 32 (4). 465-480
5. Maggiori S. Treatment of xanthelasma with phosphatidylcholine. Presented at: 5th International Meeting of Mesotherapy ; Paris, France ;..
6. Rittes PG. The lipodissolve technique: clinical experience. Clin Plast Surg. 2009 ; 36 (2). 215-221
7. Hexsel D, Serra M, Mazzuco R, Dal'Forno T, Zechmeister D. Phosphatidylcholine in the treatment of localized fat. J Drugs Dermatol. 2003 ; 2 (5). 511-518
8. Hasengschwandtner F. Injection lipolysis for effective reduction of localized fat in place of minor surgical lipoplasty. Aesthetic Surg J. 2006 ; 26 (2). 125-130
9. Treacy PJ, Goldberg DJ. Use of phosphatidylcholine for the correction of lower lid bulging due to prominent fat pads. J Cosmet Laser Ther. 2006 ; 8 (3). 129-132
10. Duncan DI, Chubaty R. Clinical safety data and standards of practice for injection lipolysis: a retrospective study. Aesthetic Surg J. 2006 ; 26 (5). 575-585
11. Cinti S, Mitchell G, Barbatelli G, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 2005 ; 46 (11). 2347-2355
12. Dahlman I, Kaaman M, Olsson T, et al. A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J Clin Endocrinol Metab. 2005 ; 90 (10). 5834-5840
13. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004 ; 92 (3). 347-355
14. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 2000 ; 11 (8). 327-332
15. Seip RL, Angelopoulos TJ, Semenkovich CF. Exercise induces human lipoprotein lipase gene expression in skeletal muscle but not adipose tissue. Am J Physiol. 1995 ; 268 (2, pt 1). E229 - E236
16. Ibrahimi A, Abumrad NA. Role of CD36 in membrane transport of long-chain fatty acids. Curr Opin Clin Nutr Metab Care. 2002 ; 5 (2). 139-145
17. Bruun JM, Helge JW, Richelsen B, Stallknecht B. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am J Physiol Endocrinol Metab. 2006 ; 290 (5). E961 - E967
18. Khan T, Muise ES, Iyengar P, et al. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol. 2009 ; 29 (6). 1575-1591
19. Lijnen HR, Maquoi E, Holvoet P, et al. Adipose tissue expression of gelatinases in mouse models of obesity. Thromb Haemost. 2001 ; 85 (6). 1111-1116
20. Ozcan U, Cao Q, Yilmaz E, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 2004 ; 306 (5695). 457-461
21. Ozcan U, Yilmaz E, Ozcan L, et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science. 2006 ; 313 (5790). 1137-1140
22. Rittes PG. The use of phosphatidylcholine for correction of lower lid bulging due to prominent fat pads. Dermatol Surg. 2001 ; 27 (4). 391-392
23. Ablon G, Rotunda AM. Treatment of lower eyelid fat pads using phosphatidylcholine: clinical trial and review. Dermatol Surg. 2004 ; 30 (3). 422-427
24. Tawfik HA, Zuel-Fakkar N, Elmarasy R, Talib N, Elsamkary M, Abdallah MA. Phosphatidylcholine for the treatment of prominent lower eyelid fat pads: a pilot study. Ophthal Plast Reconstr Surg. 2011 ; 27 (3). 147-151
25. Salti G, Ghersetich I, Tantussi F, Bovani B, Lotti T. Phosphatidylcholine and sodium deoxycholate in the treatment of localized fat: a double-blind, randomized study. Dermatol Surg. 2008 ; 34 (1). 60-66
26. Rotunda AM, Weiss SR, Rivkin LS. Randomized double-blind clinical trial of subcutaneously injected deoxycholate versus a phosphatidylcholine- deoxycholate combination for the reduction of submental fat. Dermatol Surg. 2009 ; 35 (5). 792-803
27. Rotunda AM, Suzuki H, Moy RL, Kolodney MS. Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution. Dermatol Surg. 2004 ; 30 (7). 1001-1008
28. Klein SM, Schreml S, Nerlich M, Prantl L. In vitro studies investigating the effect of subcutaneous phosphatidylcholine injections in the 3T3-L1 adipocyte model: lipolysis or lipid dissolution?. Plast Reconstr Surg. 2009 ; 124 (2). 419-427
29. Gupta A, Lobocki C, Singh S, et al. Actions and comparative efficacy of phosphatidylcholine formulation and isolated sodium deoxycholate for different cell types. Aesthetic Plast Surg. 2009 ; 33 (3). 346-352
30. Palmer M, Curran J, Bowler P. Clinical experience and safety using phosphatidylcholine injections for the localized reduction of subcutaneous fat: a multicentre, retrospective UK study. J Cosmet Dermatol. 2006 ; 5 (3). 218-226